Press release
Global Infliximab Drug Market Growth to be Driven by the Rising Prevalence of Rheumatoid Arthritis During the Forecast Period of 2023-2031
The 'Global Infliximab Drug Market Size, Report and Forecast 2023-2031' by Expert Market Research gives an extensive outlook of the global infliximab drug market, assessing the market on the basis of its segments like product type, route of administration, application, distribution channel, and major regions.Infliximab Drug Market Size, Share, Price Trends, Industry Report, Key Players, Major Segments, and Forecast
The key highlights of the report include:
Market Overview (2016-2031)
• Forecast CAGR (2023-2031): 5.4%
The infliximab drug market is driven by several key factors, including the increasing prevalence of chronic inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis. These diseases are characterized by chronic inflammation, which leads to joint damage and disability in the case of rheumatoid arthritis, and intestinal inflammation and damage in the case of Crohn's disease and ulcerative colitis. Infliximab, a biologic drug, is used to treat these conditions by inhibiting the activity of the inflammatory cytokine tumour necrosis factor (TNF).
Another key driver for the infliximab drug market is the increasing adoption of biologic drugs in the treatment of inflammatory diseases. Biologic drugs, such as infliximab, are designed to target specific molecules or pathways involved in the inflammatory process, making them more effective and targeted than traditional small molecule drugs. This increased effectiveness and targeting has led to increased demand for biologic drugs, including infliximab, in the treatment of inflammatory diseases.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/infliximab-drug-market/requestsample
The rising research and development activities to create new drugs for the treatment of inflammatory diseases is also expected to drive the market for infliximab. As new drugs and therapies enter the market, the demand for infliximab is likely to increase, driving growth in the market.
In conclusion, the infliximab drug market is driven by the increasing prevalence of chronic inflammatory diseases, the increasing adoption of biologic drugs, the availability of biosimilars, and the rising research and development activities to create new drugs for the treatment of inflammatory diseases. These drivers are expected to continue to fuel growth in the market in the coming years.
Infliximab Drug Industry Definition and Major Segments
Infliximab is a biologic medication that belongs to a class of drugs called tumour necrosis factor (TNF) inhibitors. It works by blocking the action of a protein called TNF-alpha, which is involved in inflammation and the development of certain autoimmune and inflammatory diseases. Infliximab is used to treat conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis. It is administered via intravenous infusion.
Market Breakup by Product Type
• Brands Drugs
• Generic Drugs
Market Breakup by Route of Administration
• Oral
• Parenteral
• Topical
• Transdermal
• Rectal
Market Breakup by Application
• Rheumatoid Arthritis
• Crohn's Disease
• Ulcerative Colitis
• Psoriasis
Market Breakup by Distribution Channel
• Hospital Based Pharmacies
• Online Pharmacies
• Retail Pharmacies
Market Breakup by Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/infliximab-drug-market
Infliximab Drug Market Trends
The infliximab drug market is being driven by the increasing availability of biosimilars, which are similar but not identical copies of biologic drugs. Biosimilars are typically less expensive than their branded counterparts, making them more accessible to patients and healthcare providers. The availability of biosimilars for infliximab is expected to increase competition in the market and drive down prices, making the drug more accessible to patients in need.
Infliximab is a monoclonal antibody used to treat a variety of autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease. Some recent developments in the market include the approval of a biosimilar version of infliximab, which is expected to increase competition and potentially lower costs for patients. Additionally, there have been studies exploring the use of infliximab in new indications such as lupus and sarcoidosis, which could expand the market for the drug.
Key Market Players
The major players in the infliximab drug market report are Zydus Cadila, Pfizer, Samsung Bioepis, Celltrion, Sandoz, AbbVie, Hospira, Epirus Biopharmaceuticals, Janssen Biotech, Inc., NAPP Pharmaceuticals, Nippon Kayaku, and Alvogen. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter's Five Forces Models.
More Reports:
https://www.marketwatch.com/press-release/global-contraceptive-drugs-market-to-be-driven-by-the-increasing-availability-of-free-subsidised-contraceptive-drugs-in-the-forecast-period-of-2022-2027-2022-11-03?mod=search_headline
https://www.marketwatch.com/press-release/global-network-forensics-market-to-be-driven-by-the-rising-application-of-network-forensics-in-law-enforcement-agencies-in-the-forecast-period-of-2022-2027-2022-11-03?mod=search_headline
https://www.marketwatch.com/press-release/global-baggage-handling-system-market-to-reach-a-value-of-usd-1312-billion-by-2027-2022-11-03?mod=search_headline
https://www.marketwatch.com/press-release/global-canned-food-market-to-be-driven-at-a-cagr-of-397-in-the-forecast-period-of-2022-2027-2022-11-02?mod=search_headline
https://www.marketwatch.com/press-release/global-chlorinated-polyethylene-market-to-be-driven-by-the-rising-application-of-the-product-in-the-construction-sector-in-the-forecast-period-of-2022-2027-2022-11-02?mod=search_headline
https://www.marketwatch.com/press-release/global-big-data-analytics-in-retail-market-to-be-driven-by-the-increasing-adoption-of-cloud-based-big-data-analytics-software-by-the-retailers-in-the-forecast-period-of-2022-2027-2022-11-02?mod=search_headline
https://www.marketwatch.com/press-release/global-automatic-weapons-market-to-be-driven-by-the-increasing-adoption-of-semi-automatic-and-fully-automatic-weapons-by-the-warfighters-in-the-forecast-period-of-2022-2027-2022-11-02?mod=search_headline
https://www.marketwatch.com/press-release/global-video-streaming-software-market-to-be-driven-by-advancements-in-low-latency-software-in-the-forecast-period-of-2022-2027-2022-11-02?mod=search_headline
https://www.marketwatch.com/press-release/global-electrosurgery-market-to-be-driven-by-the-increasing-prevalence-of-connective-tissue-diseases-in-the-forecast-period-of-2022-2027-2022-11-02?mod=search_headline
https://www.marketwatch.com/press-release/global-security-robots-market-to-be-driven-by-the-increasing-demand-for-security-robots-in-the-commercial-sector-in-the-forecast-period-of-2022-2027-2022-11-02?mod=search_headline
Media Contact
Company Name: Claight Corporation
Contact Person: Sophia Grace, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
About Us:
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients' requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Infliximab Drug Market Growth to be Driven by the Rising Prevalence of Rheumatoid Arthritis During the Forecast Period of 2023-2031 here
News-ID: 2923183 • Views: …
More Releases from Expert Market Research

Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
The global bed and bath linen market is witnessing strong growth due to increasing consumer focus on home décor, comfort, and luxury. Rising disposable incomes, urbanization, and the booming hospitality sector are further boosting demand for premium-quality bed sheets, pillowcases, towels, and bathrobes. Technological innovations in fabrics, such as antimicrobial, wrinkle-resistant, and sustainable textiles, are shaping consumer preferences. In addition, the expansion of online distribution channels has made luxury and…

Global Fruit Juice Market Size, Report and Forecast 2025-2034
The latest report from Expert Market Research titled, "Global Fruit Juice Market Size, Report and Forecast 2025-2034," offers a comprehensive analysis of the global fruit juice market, examining it across various segments such as types, flavours, distribution channels, and key regions.
The report identifies and tracks the latest trends shaping the industry and evaluates their impact on the overall market dynamics. It also provides a thorough assessment of the market, covering…

Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
According to the latest report by Expert Market Research (EMR), the global Fluorspar Market Size is projected to grow at a CAGR of 5.60% between 2025 and 2034. The market is expected to experience significant growth by 2034, driven by the increasing demand for fluorspar across industries such as manufacturing, chemicals, and metallurgy.
Fluorspar, also known as fluorite, is a key industrial mineral composed of calcium fluoride (CaF2). It is crucial…

Why will smart pulse oximeters market hit $3.50Bn by 2034?
smart pulse oximeters market Overview
The smart pulse oximeters market has become a pivotal part of modern healthcare infrastructure, especially in the wake of increasing cardiovascular and respiratory ailments. These technologically enhanced devices measure blood oxygen saturation and pulse rate, often offering wireless connectivity to mobile apps for better health tracking. Their growing application in hospitals, ambulatory settings, and home healthcare environments reflects the market's evolving dynamics. Key drivers include the…
More Releases for Infliximab
Adalimumab, Infliximab, and Etanercept Biosimilars Market Trends 2024
"The Business Research Company recently released a comprehensive report on the Global Adalimumab, Infliximab and Etanercept Biosimilars Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your…
Infliximab Biosimilar Market Research Report 2024
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1060
According to the latest research by InsightAce Analytic, the global…
Infliximab Biosimilar Insight, 2023 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
Infliximab Biosimilar Insight, 2023 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
Infliximab and Biosimilar Market 2021 | Detailed Report
Infliximab and Biosimilar Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Infliximab and Biosimilar Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5048518
The report provides a comprehensive analysis of company profiles listed below:
- Janssen Biotech
- Merck and…